Enterome’s microbiome-based approach for cancer vaccines boosted by $52M financing June 25, 2020 By Nuala Moran No Comments LONDON – Enterome SA has raised €46.3 million (US$52.6 million) in a mixture of debt and equity, enabling it to take a new type of cancer vaccine, based on microbiome-derived antigens that mimic neoantigens expressed on tumor cells, into the clinic.Read More